WAUKESHA, Wis.--(BUSINESS WIRE)--Emphasizing its commitment to low-dose medical imaging, GE Healthcare (NYSE:GE) today announced 510(k) clearance of its revolutionary Computed Tomography (CT) technology, called Veo,* which may help physicians deliver accurate diagnoses by enabling profound CT image clarity at dramatically lower dose.1 Veo represents the CT industry’s first Model-based Iterative Reconstruction (MBIR) technique, and is already available on GE Discovery* CT750 HD systems in Europe, Canada and regions of Asia.
